ID   9C11-14
AC   CVCL_C6XV
DR   ABCD; ABCD_AN718
DR   ABCD; ABCD_AN719
DR   ABCD; ABCD_AN720
DR   Wikidata; Q123030340
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
RX   Patent=US8329181;
RA   Martin, Joel H.
RA   Wang, Li-Hsien
RA   Stevens, Sean
RA   Allison, Erin M.
RT   "Methods for treating B-cell lymphoma by administering an anti-CD20
RT   antibody.";
RL   Patent number US8329181, 11-Dec-2012.
//